NEW YORK (GenomeWeb) – Invitae has priced its offering of 11,111,111 shares of its common stock at a price of $4.50 per share.

The genetic testing firm had said earlier this week that it expected to offer 7,122,507 shares. But its stock price has tumbled since announcing the planned offering, from a close of $7.00 on Monday to a close of $4.84 yesterday on the New York Stock Exchange.

Invitae said that it expects gross proceeds from the offering of around $50.0 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.